Accueil>>Signaling Pathways>> Stem Cell>> Notch>>Brontictuzumab

Brontictuzumab (Synonyms: OMP 52M51; Anti-Human NOTCH1 Recombinant Antibody)

Catalog No.GC68809

Brontictuzumab (OMP 52M51) est un anticorps monoclonal (MAb) qui peut inhiber le signal Notch1. Brontictuzumab se lie sélectivement à la région de régulation négative de Notch1. Brontictuzumab peut inhiber la prolifération des cellules tumorales. Brontictuzumab peut être utilisé dans la recherche sur la leucémie et les lymphomes.

Products are for research use only. Not for human use. We do not sell to patients.

Brontictuzumab Chemical Structure

Cas No.: 1447814-75-6

Taille Prix Stock Qté
1mg
405,00 $US
En stock
5mg
1 053,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Avis

Review for Brontictuzumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Brontictuzumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.